Biotech Values

[ghmm]

My guess was he bought the position to do a reverse merger with Turing. As I recall rtrx was the same way (and I thought it cost him considerably more when factoring the cost of the equity he gave up). Given the sharp rise I wonder if scraps that idea and takes a short-term gain instead.